Dengue viruses (DENV) are major human pathogens, transmitted between people mainly by *Aedes aegypti* mosquitoes. Recently, the endosymbiont bacteria Wolbachia was horizontally introduced into Ae. Aegypti; Wolbachia infection non-specifically impairs DENV replication in these mosquitoes opening up a potential new strategy for dengue control. This project will test the hypothesis that DENV cannot easily develop resistance to the mechanisms by which Wolbachia blocks virus replication. Using contemporary viruses currently circulating in Vietnam, we will perform 30 cycles of repeated passage of DENV in wild-type and Wolbachia-infected Ae. Aegypti (wMel strain). This experimental system maximizes the possibility of observing selective pressure by wMel on DENV populations in mosquito tissues. We will use intermittent quantitative virology and virus genome sequencing to detect changes over time in the genotype and phenotype of DENV in Ae. aegypti. The results will provide valuable insights into how easily DENV adapt to Wolbachia in a controlled system. If Wolbachia specific evolution is observed, then we will test the infectiousness and replication profile of such viruses in cultured human cells. The results will deliver the first evidence of the likelihood of DENV "escape" from wMel, with implications for future and ongoing field releases of wMel in dengue-endemic countries.
